Proteovant Therapeutics
Drew has 30+ years of leadership in public & private healthcare companies. He serves as Vant Portfolio Operating Partner for Roivant Sciences, Inc. (ROIV) and on the board of Immunovant, Inc. (IMVT).
This person is not in any offices
Proteovant Therapeutics
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.